Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Krystal Biotech buy Guggenheim

Krystal Biotech
Start price
€233.30
25.02.26 / 50%
Target price
€240.95
25.02.27
Performance (%)
23.79%
Price
€288.80
09:31
Summary
This prediction is currently active. The prediction currently has a performance of 23.79%. This prediction currently runs until 25.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Krystal Biotech 1.736% 1.736%
iShares Core DAX® 0,44 % 5,90 %
iShares Nasdaq 100 1,06 % 0,92 %
iShares Nikkei 225® 1,77 % 1,23 %
iShares S&P 500 0,37 % 1,92 %

Comments by Guggenheim for this prediction

In the thread Krystal Biotech diskutieren
Prediction Buy
Perf. (%) 23.79%
Target price 240.946
Change
Ends at 25.02.27

Krystal Biotech (KRYS) had its price target raised by Guggenheim from $224.00 to $284.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat

Guggenheim 
0
Report Share
25.02.26

Stopped prediction by Guggenheim for Krystal Biotech

buy
Krystal Biotech

Start price
Target price
Perf. (%)
€120.90
07.05.25
€166.60
07.05.26
113.56%
08.05.26

Guggenheim 
07.05.25 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€152.00
27.02.24
€161.18
27.02.25
14.14%
28.02.25

Guggenheim 
27.02.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€77.50
28.02.23
€95.04
28.02.24
93.55%
29.02.24

Guggenheim 
28.02.23 50%